Antiangiogenic peptide agents

Details Antiangiogenic peptide agents Antiangiogenic peptide agents

2007-11-27

2007-11-27

Saoud, Christine J. (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S399000, C530S300000

Reexamination Certificate

active

10714067

ABSTRACT:
The current invention provides novel antiangiogenic peptides which correspond to about 133 consecutive amino acids of the N-terminal sequence of growth hormone.

REFERENCES:
patent: 4189426 (1980-02-01), Li
patent: 4725549 (1988-02-01), Cooke et al.
patent: 4853332 (1989-08-01), Mark
patent: 4959314 (1990-09-01), Mark et al.
patent: 5217867 (1993-06-01), Evans et al.
Heymsfield et al. J. Clin. Invest. 60: 563-570, 1977.
Reagan et al. Proc. Nat. Acad. Sci. USA 72(5): 1684-1686, 1975.
Tokunaga et al. Eur. J. Biochem. 153: 445-449, 1985.
Khurana et al. Endocrinology 140(9)4127-4132, 1999.
Corbacho et al., J. Endocrinology 173(219-238)2002.
Goffin et al., Sequence-Function Relationships Within the Expanding Family of Prolactin, Growth Hormone, Placental Lactogen, and Related Proteins in Mammals*, Edocrine Reviews, vol. 17, No. 4.
Ampudia, X. et al. European Journal of Obstetrics, Gynecology, and Reproductive Biology (abstract) 46(101-107) 1992.
Andries et al. Biochem J•281 :393-400 (1993).
Aston, R. et al. EMBO J. 2:4:493-497 (1983).
Baldocchi et al. Endocrinology 133:935-938 (1993).
Casabiell, MC. et al. Endocrinology 125:4(1967) 1989.
Clapp C. et al. Prolactin Gene Family and Its Receptors 119-122 (1988).
Clapp et al. Endocrinol. 122:2892-2898 (1988).
Clapp, C. et al. Abstract No. 1387 73rdAnn Mtg. Endoc. Soc. 1991.
Clapp et al. Endocrinol 130:3:1380-1386 (1992).
Clapp et al. Endocrinol. 121:6:2055-2064 (1987).
Clapp et al. Endocrinology 125:2:1054-1059 (1989).
Clapp et al. Endocrinology 133:1292-1299 (1993) (Weiner).
Cooke et al. The Journal Of Biological Chemistry 256:4007-4016 (1980).
Cooke The Journal Of Biological Chemistry 255:13:6502-6510 (1980).
D'Angelo, G. et al. The Endocrine Society Program & Abstracts 76thAnnual Meeting Jun. 15-18, 1994.
D'Angelo, G. et al. PNAS 92:14:6374-6378 (1995).
Ferrara et al. The Endocrine Society 70thAnnual Meeting, Jun. 8-11, 1988.
Ferrara et al. Endocrinology 129:2:896-900 (1991).
Fukuoka, H. et al. Horm. Res. 35(suppl 1)58-63.
Kim, K.J. et al. Nature 362:841-844 (1993).
Luck, D.L. et al. Protein Engineering 5:559-567 (1992).
Martinez-Rodriguez, H.G. et al. Archives of Medical Research 28:4(507-512) 1997.
Mitra et al. Biochemical and Biophysical Research Communications 95:4:1760-1767 (1980).
Nicoll et al. Endocrine Reviews 7(2):169-203 (1986).
Russell et al. The Journal Of Biological Chemistry 254:2296-2301 (1979).
Russell et al. The Journal Of Biological Chemistry 256:1:296-300 (1981).
Schneider et al. The Journal Of Biological Chemistry 256:1:301-303 (1981).
Sinha et al. J. Clim Endoc. & Metab 60:2:239-243 (1985).
Unlisted Drugs 40(10):185, Oct. 1988.
Vick, R.S. et al. Biochem Biophys Acta 931:196-204 (1987).
Warner, M.D: et al. Horm. Metab. Res. 25(425-429) 1992.
Cunningham et al., Receptor and Antibody Epitopes in Human Growth Hormone Identified by Homolog-Scanning Mutagenesis, Science, vol. 243. pp. 1330-1336. 1989.

Affiliated with

Also associated with

Rating

Antiangiogenic peptide agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiangiogenic peptide agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic peptide agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3804988